IMRX vs NVCT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 25, 2026

IMRX

66.1
AI Score
VS
IMRX Wins

NVCT

43.3
AI Score

Investment Advisor Scores

IMRX

66score
Recommendation
HOLD

NVCT

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IMRX NVCT Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -99.8% 0.0% NVCT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 66.1/100 43.3/100 IMRX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IMRX 1M: -14.1% · 3M: -14.4% NVCT 1M: -7.3% · 3M: +2.6%

Current Technical Phase

IMRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 41

RSI (14): 40.7 · Price: $3.73

NVCT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.8 · Price: $20.05

Fundamentals Snapshot

Metric IMRX NVCT
Market Cap — —
Forward P/E -3.0 -17.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin 349.1% —
Operating Margin 0.0% 0.0%
EPS -0.93 -1.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IMRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.